Hamilton Lane Venture Capital & Growth Fund has initiated a tender offer to repurchase shares from its shareholders. The fund aims to buy back up to 3% of its net assets, which is approximately $10.3 million, or around 502,270 shares. This move is significant as it provides an opportunity for shareholders to liquidate part of their investments in a competitive market.

The tender offer, filed with the SEC on November 3, 2026, allows shareholders to tender their shares at their net asset value (NAV) as of December 31, 2026. Shareholders must submit their tender requests by 11:59 p.m. Eastern Time on December 3, 2026. The decision to repurchase shares reflects the fund's strategy to manage its capital effectively.

Background

Hamilton Lane Venture Capital & Growth Fund is a closed-end, non-diversified management investment company organized as a Delaware statutory trust. It is registered under the Investment Company Act of 1940. The Fund's principal executive office is located in Conshohocken, Pennsylvania. The fund focuses on providing long-term capital appreciation for its investors, and its shares are not traded on any established market.

What the Filing Says

The filing indicates, "Hamilton Lane Venture Capital and Growth Fund... is offering to purchase Shares in the Fund in an amount up to approximately 3.00% of the net assets of the Fund as of September 30, 2026." As of that date, the Fund held approximately $244.5 million in Class Y Shares, $96.1 million in Class I Shares, and $2.2 million in Class R Shares.

Impact

This tender offer may significantly impact shareholders looking to liquidate their investments. Those who choose to participate will have the opportunity to sell their shares back to the fund at their NAV, calculated as of the Valuation Date. However, shareholders must also consider the implications of reduced assets in the fund, which could affect the remaining shareholders.

What's Next

Shareholders interested in participating in the tender offer must submit their requests by December 3, 2026. The Fund reserves the right to extend the offer, which could alter the timeline for shareholders. Further filings may occur as the deadline approaches, but details were not available in the SEC filing.